Kerala High Court directs Central government to consider compulsory licensing of breast cancer drug Ribociclib

The Court called for emergent action noting that at present, an alarming number of fatalities among breast cancer patients can be attributed to the inability to afford the prohibitively priced drug.
Kerala High Court directs Central government to consider compulsory licensing of breast cancer drug Ribociclib
Ernakulam bench of Kerala High Court and Breast cancer

The Kerala High Court recently directed the Department for Promotion of Industry and Internal Trade (DPIIT) under the Union Ministry of Commerce and Industry to consider compulsory licensing of life-saving breast cancer drug, Ribociclib [xxx v. Union of India]

Want to read the full story?

We’re glad you’re enjoying this story. Subscribe to any of our plans to continue reading the story.

Already have an account? Sign In

Related Stories

No stories found.
Bar and Bench - Indian Legal news
www.barandbench.com